Vitamin E could be used as a prevention strategy for the occurrence of Parkinson's disease (PD), a new study assessing data from 13,340 participants concluded.
Probiotic supplementation may be an affordable and safe adjuvant treatment option for cognitivie decline management in patients with Parkinson's Disease (PD), according to a new systematic review and meta-analysis.
Research continues to build the nutritional toolbox that can be accessed to help improve psychiatric outcomes by boosting the production of various neurotransmitters, a new review asserts.
Excessive iron intake may increase the risk of developing Parkinson’s disease (PD) and calls into question the benefit of supplementation where clinical deficiency is not diagnosed, say scientists.
Changes in eating habits can have a beneficial effect on the condition of our body, but also on the development and course of many diseases, researchers say.
Researchers looking into the effect of vitamin D on patients with Parkinson’s Disease (PD) are confident that it can slow down the worsening of some symptoms.
Using a nanocarrier delivery system, the olive oil-derived extract Hydroxytyrosol can act as a protective agent against Parkinson’s-related neurodegeneration, according to a new study from the Centre for Nutraceuticals, University of Westminster.
Researchers have developed an 'organs-on-a-chip' system that models the interactions between the brain, gut microbiome, liver, and colon in patients with Parkinson’s disease.
Polish microbiome firm Ardigen are to team up with The BioCollective in an agreement that looks to identify microbiome- based biomarker candidates for use in addressing Parkinson’s Disease (PD).
An 'exciting' new study into a specific probiotic strain has suggested its ability to slow, and perhaps even reverse, build-ups of a protein associated with the development of Parkinson's.
Scientists have reviewed the evidence for using faecal transplantation and pre- and probiotics in patients with Parkinson's Disease and concluded that these methods should not be used until further research is conducted.
Parkinson’s disease (PD) ‘starts in the gut’ says an expert, who spoke of a study that identifies the gut-brain axis and change in microbiome environment as playing key roles in disease onset and progression.
